2025-2034 Drug-Coated Balloons Market Roadmap: Insights for Competitive Advantage

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Drug-Coated Balloons Market Size By 2025?
In recent times, the market size for drug-coated balloons has seen a swift expansion. It is projected to escalate from $1.08 billion in 2024 to $1.24 billion in 2025, growing at a compound annual growth rate (CAGR) of approximately 14.6%. The significant growth in the historical period can be linked to the escalating burden of cardiovascular diseases, growing demand for less invasive surgical procedures, prevalence of peripheral artery disease (pad), decreasing rates of restenosis, and progressive advancements in the sector of interventional cardiology.

How Big Is the Drug-Coated Balloons Market Size Expected to Grow by 2029?
Anticipations project substantial expansion for the drug-coated balloons market in the upcoming years. The projected value is around $2.2 billion in 2029, with a compound annual growth rate (CAGR) of 15.5%. The amplified growth during the forecast interval can be accredited to the escalating age demographics, broadening of utilizations and indications, concentration on outpatient and ambulatory care, amalgamation with pharmaceutical delivery improvements, and worldwide health endeavors. Key trends in the forecasted scenario include endorsements for new drug formulations, the concentration on reducing adverse effects, the emergence of bioresorbable coatings, market growth in developing economies, and patient-focused strategies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Which Key Market Drivers Powering Drug-Coated Balloons Market Expansion and Growth?
The growth of the drug-coated balloons market is predicted to be driven by an increase in the incidence of coronary artery disease. This is a health condition characterized by the constriction or blockage of the arteries that supply blood to the heart muscle, resulting in heart attacks. Drug-coated balloons are medical tools utilized in the management of this disease. They work by releasing a drug into the artery during the procedure to deter restenosis, or the artery getting narrow again after angioplasty. For example, a study by a U.S. based organization published in the Journal of the American College of Cardiology in August 2022, predicts a surge in all four cardiovascular risk factors, namely diabetes, by 39.3%, dyslipidemia by 27.6%, hypertension by 25.1%, and obesity by 18.3% among the general U.S. population from 2025 to 2060. Furthermore, heart failure and ischemic heart disease are expected to have the most alarming escalation in rates with 33.4% and 30.7% respectively, followed by heart attacks and strokes at 16.9% and 33.8%. This provides further impetus to anticipate a surge in the prevalence of coronary artery disease, which will likely stimulate the drug-coated balloon market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Drug-Coated Balloons Market?
One of the leading trends noticeable in the drug-coated balloon market is product innovation. Major players in this market are devoting their resources to create advanced and innovative solutions in order to consolidate their market standing. For example, Becton, inson, and Company (BD), a medical technology entity based in the US, initiated the PREVISION first-in-human trial for a peripheral sirolimus drug-coated balloon (DCB) in August 2022. The objective of this trial is to evaluate the safety and effectiveness of the sirolimus DCB in managing patients suffering from peripheral artery disease, a condition that significantly deteriorates mobility and quality of life.

What Are the Emerging Segments in the Drug-Coated Balloons Market?
The drug-coated balloons market covered in this report is segmented -

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications
2) By Drug Type: Paclitaxel, Sirolimus
3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:
1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons
2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons
3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp

Who Are the Global Leaders in the Drug-Coated Balloons Market?
Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

Which are the Top Profitable Regional Markets for the Drug-Coated Balloons Industry?
North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10829

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.